ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A Prospective Study of Gemcitabine and Carboplatin as First-Line Therapy in Advanced Non-Small Cell Lung Cancer: Toxicity of a Three- Versus a Four-Week Schedule
Seminars in Oncology
◽
10.1016/s0093-7754(01)80003-8
◽
2001
◽
Vol 28
◽
pp. 10-14
◽
Cited By ~ 11
Author(s):
Bárbara Parente
◽
Ana Barroso
◽
Sara Conde
◽
Tânia Guimarăes
◽
Jorge Seada
Keyword(s):
Lung Cancer
◽
Prospective Study
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
A Prospective Study
Download Full-text
Related Documents
Cited By
References
A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: Toxicity of a three- versus a four-week schedule
Seminars in Oncology
◽
10.1053/sonc.2001.23804
◽
2001
◽
Vol 28
(3H)
◽
pp. 10-14
◽
Cited By ~ 9
Author(s):
B[aacute]rbara Parente
◽
Ana Barroso
◽
Sara Conde
◽
T[acirc ]nia Guimar[atilde]es
◽
Jorge Seada
Keyword(s):
Lung Cancer
◽
Prospective Study
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
A Prospective Study
Download Full-text
Faculty Opinions recommendation of Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717964584.793468557
◽
2013
◽
Author(s):
Bruno Andreoni
◽
Gianmarco Contino
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Safety And Efficacy
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice
Journal of Cancer
◽
10.7150/jca.15180
◽
2016
◽
Vol 7
(11)
◽
pp. 1515-1523
◽
Cited By ~ 3
Author(s):
Yi-Hsin Liang
◽
Yu-Yun Shao
◽
Bin-Chi Liao
◽
Ho-Sheng Lee
◽
James Chih-Hsin Yang
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Daily Practice
◽
Cytotoxic Chemotherapy
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study
Lung Cancer
◽
10.1016/j.lungcan.2018.08.019
◽
2018
◽
Vol 125
◽
pp. 273-281
◽
Cited By ~ 26
Author(s):
Shirish M. Gadgeel
◽
James P. Stevenson
◽
Corey J. Langer
◽
Leena Gandhi
◽
Hossein Borghaei
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Platinum Based Chemotherapy
Download Full-text
Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer
Scientific Reports
◽
10.1038/s41598-017-11404-9
◽
2017
◽
Vol 7
(1)
◽
Cited By ~ 9
Author(s):
Yi Chen
◽
Jinyu Li
◽
Shixue Chen
◽
Yibao Zhang
◽
Yi Hu
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
EGFR Inhibitors as First-Line Therapy in Advanced Non-small Cell Lung Cancer
Journal of Thoracic Oncology
◽
10.1097/jto.0b013e3181645477
◽
2008
◽
Vol 3
(3)
◽
pp. 303-310
◽
Cited By ~ 25
Author(s):
Thomas Fong
◽
Daniel Morgensztern
◽
Ramaswamy Govindan
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Egfr Inhibitors
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer
Therapeutics and Clinical Risk Management
◽
10.2147/tcrm.s3195
◽
2009
◽
pp. 781
Author(s):
Filippo de Marinis
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
P2-305: Immediate versus delayed docetaxel after first-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer: A Phase III trial report with survival update
Journal of Thoracic Oncology
◽
10.1097/01.jto.0000284013.28545.c7
◽
2007
◽
Vol 2
(8)
◽
pp. S693-S694
Author(s):
J Schiller
◽
S.R. Dakhil
◽
A.P. Lyss
◽
D.M. Loesch
◽
D Waterhouse
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Iii
◽
Small Cell Lung
◽
First Line
◽
Phase Iii Trial
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer
Cancer Research and Treatment
◽
10.4143/crt.2005.37.6.332
◽
2005
◽
Vol 37
(6)
◽
pp. 332
Author(s):
Nam-Su Lee
◽
Hee-Sook Park
◽
Jong-Ho Won
◽
Dae-Sik Hong
◽
Su-Taek Uh
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Competing Immune Biomarkers in the Selection of First-line Therapy in Non-small Cell Lung Cancer
Oncology & Hematology Review (US)
◽
10.17925/ohr.2018.14.2.67
◽
2018
◽
Vol 14
(2)
◽
pp. 67
Author(s):
Khaled A Tolba
◽
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Immune Biomarkers
◽
Selection Of
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close